MGRX Key Statistics, Chart & Performance
The current stock price of MGRX is 0.5505 USD. In the past month the price decreased by -22.79%. In the past year, price decreased by -81.59%.
MGRX Technical Analysis
MGRX Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to MGRX. MGRX may be in some trouble as it scores bad on both profitability and health.
MGRX Financial Highlights
Over the last trailing twelve months MGRX reported a non-GAAP Earnings per Share(EPS) of -3.03. The EPS increased by 48.53% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -121.68% | ||
| ROE | -127.89% | ||
| Debt/Equity | 0.01 |
MGRX Forecast & Estimates
MGRX Ownership
About MGRX
Company Profile
Mangoceuticals, Inc. engages in developing, marketing, and selling men's wellness products and services via a telemedicine platform. The company is headquartered in Dallas, Texas. The company went IPO on 2023-03-21. The firm connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com, for the provision of care via telehealth on its customer portal. The company has developed and is commercially marketing a brand of erectile dysfunction (ED) products under the brand name Mango, a brand of hair-loss products under the brand name Grow, a brand of hormone balance and therapy products under the name Mojo, and a brand of weight-loss products under the brand name Slim. The Mango ED product includes the three ingredients: Either Sildenafil (the active ingredient in Viagra) or Tadalafil (the active ingredient in Cialis), and Oxytocin. Mango GROW includes four ingredients: Minoxidil (the active ingredient in Rogaine) and Finasteride (the active ingredient in Propecia), Vitamin D3 and Biotin, which are available as dietary supplements.
Company Info
MANGOCEUTICALS INC
15110 Dallas Pkwy, Suite 600
Dallas TEXAS US
Employees: 0
Phone: 18336264679
MANGOCEUTICALS INC / MGRX FAQ
What does MGRX do?
Mangoceuticals, Inc. engages in developing, marketing, and selling men's wellness products and services via a telemedicine platform. The company is headquartered in Dallas, Texas. The company went IPO on 2023-03-21. The firm connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com, for the provision of care via telehealth on its customer portal. The company has developed and is commercially marketing a brand of erectile dysfunction (ED) products under the brand name Mango, a brand of hair-loss products under the brand name Grow, a brand of hormone balance and therapy products under the name Mojo, and a brand of weight-loss products under the brand name Slim. The Mango ED product includes the three ingredients: Either Sildenafil (the active ingredient in Viagra) or Tadalafil (the active ingredient in Cialis), and Oxytocin. Mango GROW includes four ingredients: Minoxidil (the active ingredient in Rogaine) and Finasteride (the active ingredient in Propecia), Vitamin D3 and Biotin, which are available as dietary supplements.
Can you provide the latest stock price for MANGOCEUTICALS INC?
The current stock price of MGRX is 0.5505 USD. The price decreased by -9.99% in the last trading session.
Does MGRX stock pay dividends?
MGRX does not pay a dividend.
How is the ChartMill rating for MANGOCEUTICALS INC?
MGRX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
How many employees does MANGOCEUTICALS INC have?
MANGOCEUTICALS INC (MGRX) currently has 0 employees.
What is the ownership structure of MANGOCEUTICALS INC (MGRX)?
You can find the ownership structure of MANGOCEUTICALS INC (MGRX) on the Ownership tab.
What is the outstanding short interest for MANGOCEUTICALS INC?
The outstanding short interest for MANGOCEUTICALS INC (MGRX) is 7.04% of its float.